Opportunity Information: Apply for RFA HG 13 013

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Interpreting Variation in Human Non Coding Genomic Regions Using Computational Approaches and Experimental Assessment (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172 Human Genome Research 93.279 Drug Abuse and Addiction Research Programs 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control.
  • This funding opportunity was created on Jan 7, 2015 and posted on Sep 30, 2013.
  • Applicants must submit their applications by May 21, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments For profit organizations other than small businesses State governments Independent school districts City or township governments Native American tribal governments (Federally recognized) Special district governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Apply for RFA HG 13 013

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH Funding Opportunity Announcement RFA-HG-13-013, titled "Interpreting Variation in Human Non Coding Genomic Regions Using Computational Approaches and Experimental Assessment (R01)," supports research projects that aim to make sense of genetic variation in the parts of the human genome that do not code for proteins. Even though these regions do not produce proteins directly, they contain many regulatory elements and other functional sequences that can influence how genes are turned on or off, when and where they act, and how biological pathways behave. The central purpose of this FOA is to spur the development of genuinely innovative computational methods that can interpret whole-genome sequencing data in a way that helps researchers pinpoint which noncoding variants are most likely to have functional consequences tied to disease risk or other observable traits.

A key theme of the opportunity is integration. Applicants are expected to build approaches that combine whole-genome sequence information with other relevant data types, including (but not limited to) datasets describing genome function, phenotypes, patterns of genetic variation across populations, and other genomic or biological features. The practical goal is to move beyond simply listing large numbers of noncoding variants and instead identify, prioritize, or substantially narrow the set of candidate variants that may be causal or mechanistically important. In other words, the FOA targets tools and frameworks that can help translate noncoding variation into testable hypotheses about function and trait association, improving researchers' ability to connect DNA sequence differences to biological impact.

Another major requirement is evaluation through experimental evidence. The FOA emphasizes that the accuracy of the computational approaches should be assessed using experimental data, meaning applicants should have a plan to validate, benchmark, or otherwise ground-truth predictions against laboratory-derived results. This could include using existing experimental datasets or generating new experimental measurements to test whether computationally prioritized variants actually affect regulatory activity, gene expression, cellular phenotypes, or other functional readouts. The point is not only to create sophisticated prediction models, but also to demonstrate, with experimental support, that the models meaningfully distinguish functional or trait-relevant variants from background variation.

This is an R01 grant mechanism under the NIH, categorized as a discretionary grant and tied to health and education-related research activities. It is linked to multiple CFDA program areas, including human genome research and several disease-focused areas such as cancer and drug abuse/addiction research programs, reflecting the broad relevance of noncoding variant interpretation across biomedical fields. The posted date for the announcement was September 30, 2013, with key dates including an original closing date of January 21, 2015, and a current closing date listed as May 21, 2015, with an archive date of June 21, 2015. The listed award ceiling is $500,000, and there is no cost sharing or matching requirement, which means applicants are not required to contribute non-federal funds as a condition of the award.

Eligibility is broad and includes many organization types: small businesses; for-profit organizations (other than small businesses); nonprofits with or without 501(c)(3) status; public and private institutions of higher education; and a range of government entities (state, county, city/township, special districts, independent school districts, public housing authorities). The FOA also explicitly includes a wide array of additional eligible applicants, such as historically underrepresented and mission-specific institutions (for example HBCUs, Hispanic-serving institutions, AANAPISI institutions, tribal colleges and universities, Alaska Native and Native Hawaiian serving institutions), faith-based or community-based organizations, and eligible federal agencies. Importantly, non-U.S. entities are eligible: foreign organizations and foreign institutions can apply, non-U.S. components of U.S. organizations are eligible, and foreign components (as defined by NIH policy) are allowed. This design signals NIH interest in encouraging broad participation and drawing on global expertise in computational genomics and functional genomics.

Overall, this opportunity is aimed at advancing the state of the art in noncoding variant interpretation by funding research that couples computational innovation with experimental assessment. The intended outcome is a set of methods that can more reliably prioritize noncoding variants from whole-genome data, using integrated functional and phenotypic evidence, so that researchers can more efficiently identify variants likely to influence organismal function, disease susceptibility, or other important traits. For full details, NIH provided an official announcement page (http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-13-013.html) and contact support through the NIH Office of Extramural Research webmaster for access or technical issues.

Frequently Asked Questions (FAQs)

What is the funding opportunity called?

The opportunity is NIH Funding Opportunity Announcement (FOA) RFA-HG-13-013, titled "Interpreting Variation in Human Non Coding Genomic Regions Using Computational Approaches and Experimental Assessment (R01)."

What is the main goal of this FOA?

The FOA aims to spur genuinely innovative computational methods that interpret whole-genome sequencing data to help pinpoint which noncoding genetic variants are most likely to have functional consequences related to disease risk or other observable traits.

What parts of the genome does this FOA focus on?

It focuses on human noncoding genomic regions, meaning regions that do not code for proteins but may contain regulatory elements and other functional sequences that affect when, where, and how genes are turned on or off and how biological pathways behave.

Why does NIH emphasize noncoding variation in this FOA?

Even though noncoding regions do not directly produce proteins, they can strongly influence gene regulation and biological function. The FOA is designed to help researchers interpret noncoding differences in DNA sequence in ways that connect them to biological impact, disease susceptibility, or other traits.

What type of research projects is NIH trying to support through this announcement?

NIH is supporting projects that develop computational tools, methods, or frameworks that go beyond cataloging noncoding variants and instead identify, prioritize, or substantially narrow the set of candidate variants likely to be causal or mechanistically important.

Is integration of multiple data types required or encouraged?

Integration is a key theme. Applicants are expected to combine whole-genome sequence information with other relevant data types, including (but not limited to) datasets describing genome function, phenotypes, population patterns of genetic variation, and other genomic or biological features.

What does the FOA mean by moving beyond listing large numbers of variants?

The FOA is targeting methods that translate large variant lists into testable, prioritized candidates. The practical goal is to identify which noncoding variants are most likely to matter biologically or mechanistically, rather than producing broad, unfiltered catalogs.

What kinds of outcomes should proposed methods enable?

The intended outcome is improved ability to connect DNA sequence differences in noncoding regions to biological impact by generating testable hypotheses about function and trait association, and by reliably prioritizing variants from whole-genome data.

Does the FOA require experimental validation of computational predictions?

Yes. A major requirement is that the accuracy of computational approaches should be assessed using experimental data. Applicants should include a plan to validate, benchmark, or ground-truth predictions against laboratory-derived results.

Can applicants use existing experimental datasets, or must they generate new data?

The FOA allows either approach. Evaluation could use existing experimental datasets or generate new experimental measurements to test whether prioritized variants affect regulatory activity, gene expression, cellular phenotypes, or other functional readouts.

What is the emphasis of the experimental component?

The emphasis is not only on building sophisticated prediction models, but also on demonstrating with experimental support that the models meaningfully distinguish functional or trait-relevant variants from background variation.

What NIH grant mechanism is used for this opportunity?

This opportunity uses the NIH R01 grant mechanism.

How is this grant categorized?

It is categorized as a discretionary grant tied to health and education-related research activities.

What program areas (CFDA) is this FOA linked to?

It is linked to multiple CFDA program areas, including human genome research and several disease-focused areas such as cancer and drug abuse/addiction research programs, reflecting broad relevance across biomedical fields.

What is the award ceiling listed for this FOA?

The listed award ceiling is $500,000.

Is cost sharing or matching required?

No. There is no cost sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of the award.

When was the FOA posted?

The posted date for the announcement was September 30, 2013.

What are the key closing dates shown for this FOA?

The FOA lists an original closing date of January 21, 2015, and a current closing date of May 21, 2015.

When was the archive date for this FOA?

The archive date is listed as June 21, 2015.

What types of organizations are eligible to apply?

Eligibility is broad and includes small businesses; for-profit organizations (other than small businesses); nonprofits with or without 501(c)(3) status; public and private institutions of higher education; and government entities such as state, county, city/township governments, special districts, independent school districts, and public housing authorities.

Are historically underrepresented or mission-specific institutions included in eligibility?

Yes. The FOA explicitly includes a wide array of eligible applicants such as HBCUs, Hispanic-serving institutions, AANAPISI institutions, tribal colleges and universities, Alaska Native and Native Hawaiian serving institutions, and other similar institutions described in the announcement summary.

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are explicitly included among eligible applicants.

Are federal agencies eligible to apply?

Yes. Eligible federal agencies are listed as eligible applicants.

Are non-U.S. (foreign) organizations eligible?

Yes. Foreign organizations and foreign institutions can apply. Non-U.S. components of U.S. organizations are eligible, and foreign components (as defined by NIH policy) are allowed.

What does NIH appear to be encouraging by allowing foreign eligibility?

Based on the eligibility design, NIH signals interest in broad participation and drawing on global expertise in computational genomics and functional genomics.

Where can applicants find the official FOA details?

NIH provided an official announcement page at http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-13-013.html.

Who should be contacted for access or technical issues with the announcement?

The announcement notes contact support through the NIH Office of Extramural Research webmaster for access or technical issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: NEI Translational Research Program (TRP) on therapy for Visual Disorders (R24)

Previous opportunity: AK CMI

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA HG 13 013

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA HG 13 013) also looked into and applied for these:

Funding Opportunity
Planning for a National Center for Particle Beam Radiation Therapy Research (P20) Apply for PAR 13 371

Funding Number: PAR 13 371
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 13 378

Funding Number: PA 13 378
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 13 377

Funding Number: PA 13 377
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Sub Saharan African Collaborative HIV and Cancer Consortia (U54) Apply for RFA CA 13 010

Funding Number: RFA CA 13 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $750,000
FY 2014 American Schools and Hospitals Abroad (ASHA) Program Apply for APS ASHA 14 000001

Funding Number: APS ASHA 14 000001
Agency: Agency for International Development
Category: Education Health
Funding Amount: $2,000,000
Cancer Detection, Diagnostic and Treatment Technologies for Global Health (UH2/UH3) Apply for RFA CA 13 015

Funding Number: RFA CA 13 015
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Population based Research Optimizing Screening through Personalized Regimens (PROSPR) Revision to Enhance the Collection of Cervical Cancer Screening Data (U54) Apply for RFA CA 14 001

Funding Number: RFA CA 14 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $650,000
Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 13 386

Funding Number: PAR 13 386
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Low Cost, Pragmatic, Patient Centered Randomized Controlled Intervention Trials (UH2/UH3) Apply for RFA HL 14 019

Funding Number: RFA HL 14 019
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R41/R42) Apply for PA 13 388

Funding Number: PA 13 388
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44) Apply for PA 13 387

Funding Number: PA 13 387
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Community Oncology Research Program(NCORP) Community Sites (UM1) Apply for RFA CA 13 013

Funding Number: RFA CA 13 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Community Oncology Research Program (NCORP) Research Bases (UM1) Apply for RFA CA 13 012

Funding Number: RFA CA 13 012
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UM1) Apply for RFA CA 13 014

Funding Number: RFA CA 13 014
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA MH 14 214

Funding Number: RFA MH 14 214
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Indo US Collaborative Program on Affordable Medical Devices (R03) Apply for PAR 13 390

Funding Number: PAR 13 390
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $75,000
NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 14 007

Funding Number: PAR 14 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Identification of Gene Variants for Addiction Related Traits by Next Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) Apply for PAR 14 010

Funding Number: PAR 14 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $125,000
The Palliative Care Research Cooperative (PCRC) Enhancing Sustainability and Building the Science of Palliative Care (R01) Apply for RFA NR 14 003

Funding Number: RFA NR 14 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $350,000
Revision Applications for Research on Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 012

Funding Number: PAR 14 012
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $100,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 13 013", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.